Tests a smartphone self-care programme for people with lung cancer
Tests a phone-based self-management programme to help adults with lung cancer manage symptoms.
Plain-language title generated from the registry record
Registry title: A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
Key facts
- Where
- Hong Kong, Hong KongSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT06377124, who can take part
Where in Hong Kong
- Queen Elizabeth HospitalHong Kong, Hong KongTaking people
- Queen Mary HospitalHong Kong, Hong KongNot yet recruiting
- United Christian HospitalHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Hong Kong
- Trial code
- NCT06377124
- Record updated
- 19 March 2025
- Original description
Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress, depression, sleep disturbance). The current study attempts to explore the efficacy of the Smart Self-Management Support Programme (3S) in improving quality of life of patients using self-management support programme with mobile devices.Read full original descriptionShow less
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Patients With Lung Cancer - A Pragmatic Randomized Controlled Trial With Mixed-method Evaluation
Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress, depression, sleep disturbance). The current study attempts to explore the efficacy of the Smart Self-Management Support Programme (3S) in improving quality of life of patients using self-management support programme with mobile devices.
Inclusion: Aged 18 years or above; Diagnosis of advanced-stage (stage III or stage IV) non-small cell lung cancer; Ambulatory and capable of all self-care activities (ECOG ≤2); Either undergoing or has finished oncology therapy; Mentally, cognitively and physically fit to join as determined by the doctor in charge and responsible clinical investigators; Can speak and read Chinese; Willing to complete the patient-reported outcome questionnaire; Has a smartphone with WhatsApp or WeChat; Aged 18 years or above; Family caregivers of recruited patients.
Exclusion: Previously untreated symptomatic brain metastases; Serious active infection; Severe respiratory insufficiency; Diagnosed psychiatric illness with or without medication; Family Caregivers:; Preparing for lung operation; Skeletal fragility; Inability to walk; Uncontrolled pain; Unable to speak and read Chinese; Unwilling to complete the patient-reported outcome questionnaire.
Patients:.